Denosumab treatment for postmenopausal osteoporosis increases bone density
Postmenopausal women with osteoporosis who take denosumab long-term have increased bone density, sustained low rate of fractures, and a favorable benefit/risk profile, a new multinational study finds. The results were presented ...
Jun 23, 2014
0
1